Related Experiment Video
Updated: Jun 7, 2026
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
[Guideline 'Diagnosis and treatment of inflammatory bowel disease in children']
Lissy de Ridder1, Edmond H H M Rings, Johanna C Escher
1Erasmus MC-Sophia Kinderziekenhuis, Rotterdam, Afd. Kindergeneeskunde, the Netherlands.
Insights
Pediatric inflammatory bowel disease (IBD) diagnosis and treatment require specialized guidelines due to non-specific symptoms and unique management strategies. These guidelines address nutritional therapy, immunomodulators, and the critical transition to adult care.
Area of Science:
- Pediatric Gastroenterology
- Evidence-Based Medicine
- Inflammatory Bowel Disease (IBD)
Context:
- Inflammatory bowel disease (IBD) diagnosis and management in children differ significantly from adult practices.
- Low incidence and non-specific symptoms in pediatric IBD pose diagnostic challenges for general practitioners.
- Specialized diagnostic procedures like ileocolonoscopy, upper endoscopy, and small bowel imaging are crucial.
Purpose:
- To outline evidence-based practice guidelines for the diagnosis and treatment of pediatric inflammatory bowel disease (IBD).
- To provide clear recommendations for remission induction and maintenance therapies in pediatric Crohn's disease and ulcerative colitis.
- To highlight the importance of a structured transition from pediatric to adult healthcare for IBD patients.
Summary:
- Pediatric Crohn's disease management prioritizes nutritional therapy for remission induction, followed by immunomodulators (azathioprine, mercaptopurine) for maintenance.
- Ulcerative colitis treatment begins with aminosalicylates; prednisone and/or immunomodulators are used for inadequate responses, with colectomy as a final option.
- Transitioning patients from pediatric to adult healthcare requires careful attention due to potential patient and parental reluctance to change providers.
Impact:
- Establishes standardized, evidence-based approaches for diagnosing and treating pediatric IBD, improving patient outcomes.
- Offers specific therapeutic strategies tailored to children and adolescents, addressing unique disease manifestations and treatment responses.
- Emphasizes the need for coordinated care transitions to ensure continuity and adherence to long-term IBD management.
Abstract:
A multidisciplinary working group has outlined evidence-based practice guidelines for the diagnosis and treatment of inflammatory bowel disease in children (IBD). Both diagnosis and treatment of IBD in children differ significantly from practice in adults. The incidence of IBD in children is low (5.2 per 100,000 per year in the age group 0-17 years), but most of the presenting symptoms are non-specific; therefore it is difficult for the general practitioner to recognise the disease in children. For a correct diagnosis, ileocolonoscopy and upper gastrointestinal endoscopy are necessary, often combined with radiological imaging of the small bowel. In children and adolescents with Crohn's disease, nutritional therapy is the first choice of treatment for remission induction. As maintenance treatment, immunomodulators (azathioprine or mercaptopurine) should be started from the time of initial diagnosis. In children and adolescents with ulcerative colitis, the first treatment is with aminosalicylates. Prednisone and/or immunomodulators (azathioprine, cyclosporin) are indicated if there is insufficient response to aminosalicylates. A final treatment option is colectomy. The transition from paediatric to adult health care needs special attention as the patient and his or her parents may be reluctant to change trusted contacts which they have made.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:26Inflammatory Bowel Disease I: Introduction
01:20Inflammatory Bowel Disease IV: Clinical Manifestations